Citigroup’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$218K Sell
34,189
-52,995
-61% -$338K ﹤0.01% 3304
2025
Q1
$424K Buy
87,184
+1,665
+2% +$8.09K ﹤0.01% 3022
2024
Q4
$818K Buy
85,519
+45,881
+116% +$439K ﹤0.01% 2728
2024
Q3
$331K Buy
39,638
+17,707
+81% +$148K ﹤0.01% 3253
2024
Q2
$150K Buy
21,931
+9,564
+77% +$65.2K ﹤0.01% 3306
2024
Q1
$31.3K Buy
12,367
+4,783
+63% +$12.1K ﹤0.01% 4132
2023
Q4
$18.2K Sell
7,584
-7,484
-50% -$18K ﹤0.01% 4270
2023
Q3
$51.2K Sell
15,068
-178,922
-92% -$608K ﹤0.01% 3439
2023
Q2
$1.43M Sell
193,990
-133,369
-41% -$980K ﹤0.01% 1966
2023
Q1
$3.39M Buy
327,359
+118,396
+57% +$1.23M ﹤0.01% 1284
2022
Q4
$2.47M Sell
208,963
-25,358
-11% -$299K ﹤0.01% 1385
2022
Q3
$4.92M Buy
234,321
+84,699
+57% +$1.78M ﹤0.01% 1143
2022
Q2
$4.64M Buy
149,622
+84,482
+130% +$2.62M ﹤0.01% 1157
2022
Q1
$2.68M Sell
65,140
-71,189
-52% -$2.92M ﹤0.01% 1563
2021
Q4
$5.93M Buy
136,329
+95,772
+236% +$4.16M ﹤0.01% 1178
2021
Q3
$2.03M Sell
40,557
-61,001
-60% -$3.05M ﹤0.01% 1908
2021
Q2
$6.4M Buy
101,558
+46,904
+86% +$2.95M ﹤0.01% 1271
2021
Q1
$5.08M Buy
54,654
+26,084
+91% +$2.42M ﹤0.01% 1334
2020
Q4
$2.56M Buy
28,570
+11,811
+70% +$1.06M ﹤0.01% 1566
2020
Q3
$1.73M Sell
16,759
-95,537
-85% -$9.87M ﹤0.01% 1588
2020
Q2
$8.88M Buy
112,296
+79,054
+238% +$6.25M 0.01% 834
2020
Q1
$1.92M Sell
33,242
-236
-0.7% -$13.7K ﹤0.01% 1407
2019
Q4
$1.81M Sell
33,478
-24,223
-42% -$1.31M ﹤0.01% 1768
2019
Q3
$3.02M Buy
57,701
+13,036
+29% +$682K ﹤0.01% 1336
2019
Q2
$2.16M Buy
44,665
+15,307
+52% +$740K ﹤0.01% 1582
2019
Q1
$1.48M Sell
29,358
-31,479
-52% -$1.59M ﹤0.01% 1702
2018
Q4
$3.61M Buy
60,837
+33,424
+122% +$1.98M ﹤0.01% 1197
2018
Q3
$1.81M Buy
27,413
+19,894
+265% +$1.31M ﹤0.01% 1576
2018
Q2
$380K Sell
7,519
-31,377
-81% -$1.59M ﹤0.01% 2522
2018
Q1
$2.05M Sell
38,896
-8,378
-18% -$441K ﹤0.01% 1430
2017
Q4
$2.2M Sell
47,274
-6,502
-12% -$302K ﹤0.01% 1416
2017
Q3
$2.18M Sell
53,776
-7,158
-12% -$290K ﹤0.01% 1443
2017
Q2
$2.07M Buy
60,934
+6,967
+13% +$236K ﹤0.01% 1467
2017
Q1
$1.57M Sell
53,967
-61,669
-53% -$1.79M ﹤0.01% 1578
2016
Q4
$3.8M Buy
115,636
+89,298
+339% +$2.93M ﹤0.01% 1260
2016
Q3
$830K Buy
26,338
+16,039
+156% +$505K ﹤0.01% 2077
2016
Q2
$290K Sell
10,299
-12,320
-54% -$347K ﹤0.01% 2594
2016
Q1
$821K Buy
22,619
+20,017
+769% +$727K ﹤0.01% 2243
2015
Q4
$104K Sell
2,602
-134
-5% -$5.36K ﹤0.01% 3555
2015
Q3
$78K Sell
2,736
-140
-5% -$3.99K ﹤0.01% 3302
2015
Q2
$95K Sell
2,876
-7,372
-72% -$244K ﹤0.01% 3282
2015
Q1
$295K Buy
10,248
+8,685
+556% +$250K ﹤0.01% 2649
2014
Q4
$42K Sell
1,563
-3,260
-68% -$87.6K ﹤0.01% 4193
2014
Q3
$103K Buy
4,823
+3
+0.1% +$64 ﹤0.01% 3129
2014
Q2
$108K Buy
4,820
+1,513
+46% +$33.9K ﹤0.01% 3019
2014
Q1
$84K Sell
3,307
-6,809
-67% -$173K ﹤0.01% 3629
2013
Q4
$232K Buy
10,116
+5,998
+146% +$138K ﹤0.01% 3025
2013
Q3
$78K Sell
4,118
-5,768
-58% -$109K ﹤0.01% 3321
2013
Q2
$143K Buy
+9,886
New +$143K ﹤0.01% 2996